CanSORT received a $13 million program award from the National Cancer Institute in 2012 to study the challenges of individualizing treatments for patients with breast cancer. This study seeks to better understand how women with breast cancer and their doctors decide on a variety of test and treatment options based on clinical and other factors.
The iCanCare Study involves surveys of selected women diagnosed with early stage breast cancer in the state of Georgia and Los Angeles County, California and their treating doctors – surgeons, medical oncologists, and radiation oncologists. Women are surveyed approximately 6 months after their breast cancer diagnosis and asked about their decision making experiences regarding tests and treatments for their breast cancer. Doctors are surveyed about their general perspectives and recommendations regarding breast cancer tests and treatments.
Individual patients and doctors cannot be identified in the study data and survey responses are never shared between patients and doctors.
Below are some frequently-asked questions about the I Can Care Study. Please click on each topic to learn more.
Frequently Asked Questions
Who is funding the study?
Who are the primary investigators?
How are women selected for participation?
How many women are participating?
What are participants asked to do?
What will the researchers do with the information from the study?
How long does the study last?
Who can I contact if I have a question?
What are my rights as a research subject and what will happen if I decide not to participate?
How did you get my name and contact information?
What if I don't want to answer a question?
How will you keep my information confidential?
Which doctors are being asked to participate in the study?
What are doctors asked to do?